Clinical Trial Update: TBE-vaccine to Patients With Rheumatoid Arthritis Who Are Using Immunosuppressive Drugs [Phase 2]

View source ↗

Summary

A Phase 2 trial tested the Tick-Borne Encephalitis vaccine in rheumatoid arthritis patients taking immunosuppressants. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tick-borne encephalitis vaccine (Tick-borne encephalitis vaccine)

Snippet

Sponsor: Sormland County Council, Sweden | Conditions: Rheumatoid Arthritis, Exposed to TBE-virus | Phase 2 | Status: COMPLETED